Development and validation of nomograms for predicting survival in patients with de novo metastatic triple-negative breast cancer
Abstract Metastatic triple-negative breast cancer (mTNBC) is a heterogeneous disease with a poor prognosis. Individualized survival prediction tool is useful for this population. We constructed the predicted nomograms for breast cancer-specific survival (BCSS) and overall survival (OS) using the dat...
Main Authors: | Mao-Shan Chen, Peng-Cheng Liu, Jin-Zhi Yi, Li Xu, Tao He, Hao Wu, Ji-Qiao Yang, Qing Lv |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2022-08-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-022-18727-2 |
Similar Items
-
Development and validation of nomograms predicting survival in Chinese patients with triple negative breast cancer
by: Yaping Yang, et al.
Published: (2019-06-01) -
Survival nomogram for patients with de novo metastatic breast cancer based on the SEER database and an external validation cohort
by: Lizhi Ning, et al.
Published: (2023-10-01) -
A novel conditional survival nomogram for monitoring real-time prognosis of non-metastatic triple-negative breast cancer
by: Xiangdi Meng, et al.
Published: (2023-02-01) -
Therapy options for metastatic triple negative breast cancer
by: E. V. Glazkova, et al.
Published: (2022-06-01) -
Emerging treatment strategies for metastatic triple-negative breast cancer
by: Laura A. Huppert, et al.
Published: (2022-04-01)